TELA (TELA Bio, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings
TELA Bio, Inc. Common Stock (TELA) is a publicly traded Healthcare sector company. As of May 21, 2026, TELA trades at $0.91 with a market cap of $37.16M and a P/E ratio of -1.23. TELA moved +12.15% today. Year to date, TELA is -13.73%; over the trailing twelve months it is -28.65%. Its 52-week range spans $0.50 to $3.26. Analyst consensus is strong buy with an average price target of $2.00. Rallies surfaces TELA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns TELA stock?
Hedge funds tracked by Rallies that own TELA include Orbimed Advisors and Pentwater Capital. The latest tracked quarter is Sep 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for TELA Bio, Inc. Common Stock.
TELA Key Metrics
Key financial metrics for TELA
Metric
Value
Price
$0.91
Market Cap
$37.16M
P/E Ratio
-1.23
EPS
$-0.79
Dividend Yield
0.00%
52-Week High
$3.26
52-Week Low
$0.50
Volume
48
Avg Volume
0
Revenue (TTM)
$80.81M
Net Income
$-39.84M
Gross Margin
67.25%
Top Hedge Funds Holding TELA
Orbimed Advisors holds 2.16M shares of TELA, changed -12.06% as of Sep 30, 2024.
Pentwater Capital holds 724.86K shares of TELA, changed -11.06% as of Sep 30, 2025.
Hedge funds tracked by Rallies that own TELA include Orbimed Advisors and Pentwater Capital. The latest tracked quarter is Sep 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for TELA Bio, Inc. Common Stock.
Does Rallies show 13F holders for TELA?
Yes. Rallies tracks hedge fund and 13F ownership data for TELA, including fund names, share counts, latest tracked quarter, and position changes when available.
Is TELA research on Rallies investment advice?
No. Rallies provides research, data, and educational context for TELA. It does not provide personalized investment advice.
